Elastin-derived peptides favor type 2 innate lymphoid cells in COPD
This study aimed to investigate the presence of ILC in COPD patients and examine the impact of elastin peptides on their functionality. Our findings revealed an elevated proportion of ILC2 in the peripheral blood of COPD patients, and a general activation of ILC as indicated by an increase in their cytokine secretion capacity. Notably, our study demonstrated that serum from COPD patients promotes ILC2 phenotype, likely due to the elevated concentration of IL-5, a cytokine known to favor ILC2 activation. Furthermore, we uncovered that this increase in IL-5 secretion is partially attributed to its secretion by macrophages upon stimulation by elastin peptides, suggesting an indirect role of elastin peptides on ILC in COPD. These findings shed light on the involvement of ILC in COPD and provide insights into the potential interplay between elastin breakdown, immune cells, and disease progression. Further understanding of the mechanisms underlying ILC activation and their interaction with elastin peptides could contribute to the development of novel therapeutic strategies for COPD management.PMID:38712445 | DOI:10.1152/ajplung.00306.2023
Source: American Journal of Physiology. Lung Cellular and Molecular Physiology - Category: Cytology Authors: Sarah Lahire Caroline Fichel Oc éane Rubaszewski C édric Lereverend Sandra Audonnet Vincent Visneux Jeanne-Marie Perotin Ga ëtan Deslée S ébastien Le Jan St éphane Potteaux Richard Le Naour Arnaud Pommier Source Type: research
More News: Chronic Obstructive Pulmonary | Cytology | Molecular Biology | Physiology | Smokers | Study